Virology News and Research

Latest Virology News and Research

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Net sales for the fourth quarter of fiscal 2009 were $42,461,000 as compared to $36,475,000 for the same period of the prior fiscal year, an increase of 16%. Net earnings for the fourth quarter of fiscal 2009 were $8,930,000, or $ 0.22 per diluted share, up 16% over the fourth quarter of fiscal 2008.

12 Nov 2009

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Amarillo Biosciences, Inc. reported that the American Veterinary Medical Association (AVMA) recently confirmed that a household cat in Iowa developed signs of respiratory infection caused by H1N1 influenza virus.

12 Nov 2009

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

CSL Biotherapies, a subsidiary of CSL Limited, one of the world’s leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application for accelerated approval of its seasonal flu vaccine, Afluria® (Influenza Virus Vaccine) for use in the pediatric population aged 6 months and older.

12 Nov 2009

Oregon state officials confirm that three more ferrets have tested positive for the 2009 H1N1 virus

Three more ferrets in Oregon have tested positive for the 2009 pandemic influenza H1N1 virus, state officials confirmed this afternoon, bringing the total number of cases affecting ferrets in the state to four.

12 Nov 2009

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

Emergency Management & Safety Solutions (EMS Solutions), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help companies better prepare for and prevent transmission of this year's H1N1 flu pandemic. Today, over 180 countries have experienced the H1N1 virus outbreak and approximately 6,500 people have died -- including over 1,500 in North America, according to the European Center for Disease Prevention and Control.

12 Nov 2009

New website on healthy lifestyle and its issues launched by Healthy Life Network

HealthyLifeNetwork.com is officially online and making its healthful presence known on the world-wide web. The new site has been in development for sometime but overall the time to market from concept to publish was fast-tracked by a Chicago-based team of writers, editors, designers and marketing wizards.

12 Nov 2009

UK research funders announce support for a series of H1N1 2009 research projects

Leading UK research funders today announce -7.5 million of funding for a series of projects aimed at understanding the development and spread of pandemic influenza H1N1 2009 - or 'swine flu'. The research will look at every aspect of the virus, on pig farms, in pig and human populations, and in hospital intensive care units.

11 Nov 2009

First draft of the cassava genome complete

A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.

11 Nov 2009

Hand washing: Best method for killing germs and protecting oneself from flu

Fears of contracting the H1N1 virus this flu season have people steering clear of strangers with coughs and scolding friends who don't sneeze into their crooked elbows. With everyone trying to stay germ free, hand sanitizer has become a popular means of protection. But although a quick pump from a Purell dispenser is the most convenient form of hand cleaning, is it the best?

11 Nov 2009

FDA Commissioner thanks America's doctors for their efforts during 2009 H1N1 influenza outbreak

Dr. Margaret Hamburg, Commissioner of Food and Drugs, today sent a letter to America's doctors, thanking them for their efforts during the 2009 H1N1 influenza outbreak and providing information on the safety of the 2009 H1N1 vaccines.

11 Nov 2009

World's poorest countries fail to address HIV despite low cost and effective preventive health efforts

A proven and cost-effective strategy for turning the tide on global AIDS still remains significantly underutilized, World Vision warned in advance of World AIDS Day. Efforts to prevent mother-to-baby transmission of HIV must be urgently scaled up in high-prevalence countries to avoid needless infection of children, the Christian humanitarian organization said.

11 Nov 2009

Lower socioeconomic status linked with inability to fight H1N1

People who did not earn a high school diploma could be more likely to get H1N1 and the vaccine might be less effective in them compared to those who earned a diploma, new research shows.

11 Nov 2009

Majority of pharmacists say patients should use OTC drugs at the first sign of cold and flu symptoms

A recent national survey of 505 pharmacists found that nine out of 10 pharmacists believe it is important for a patient to seek treatment early to help shorten the duration and severity of a cold.

11 Nov 2009

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

11 Nov 2009

VeriChip announces the completion of Steel Vault acquisition

VeriChip Corporation, a provider of radio frequency identification (RFID) systems for healthcare and patient-related needs, and Steel Vault Corporation, a premier provider of identity security products and services, announced today that VeriChip has completed its acquisition of Steel Vault to provide unique health and security identification tools to protect consumers and businesses. In conjunction with the merger, VeriChip has changed its name to PositiveID ("PositiveID" or the "Company").

11 Nov 2009

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

In follow-up coverage to the WHO's report on women's health, several news outlets examine the impact HIV/AIDS is having on women around the world. "In its first study of women's health, the World Health Organization said yesterday that the AIDS virus is the leading cause of death and disease among women between the ages of 15 and 44," the Associated Press/Boston Globe reports (11/10).

11 Nov 2009

GSK to donate 50M H1N1 vaccine doses to WHO in coming months

Drugmaker GlaxoSmithKline announced plans on Tuesday to donate 50 million doses of its H1N1 (swine flu) vaccine to the WHO for use in developing countries within the next few months, Reuters reports. "We expect to start receiving [the first of the H1N1 doses] at the end of the month or early December and that the full 50 million will come by the end of spring," WHO spokesman Gregory Hartl said, adding, "We hope it is the first of many donations."

10 Nov 2009

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing.

10 Nov 2009

BioVex completes $70M financing to complete OncoVEX Phase III study

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.

10 Nov 2009

Virology News and Research

Latest Virology News and Research

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

Oregon state officials confirm that three more ferrets have tested positive for the 2009 H1N1 virus

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

New website on healthy lifestyle and its issues launched by Healthy Life Network

UK research funders announce support for a series of H1N1 2009 research projects

First draft of the cassava genome complete

Hand washing: Best method for killing germs and protecting oneself from flu

FDA Commissioner thanks America's doctors for their efforts during 2009 H1N1 influenza outbreak

World's poorest countries fail to address HIV despite low cost and effective preventive health efforts

Lower socioeconomic status linked with inability to fight H1N1

Majority of pharmacists say patients should use OTC drugs at the first sign of cold and flu symptoms

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

VeriChip announces the completion of Steel Vault acquisition

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

GSK to donate 50M H1N1 vaccine doses to WHO in coming months

Aduro BioTech raises funds through its Series A-1 financing

BioVex completes $70M financing to complete OncoVEX Phase III study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production